• Inicio
• artemisia annua
• Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions

Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions

5 (436) · € 4.50 · En stock

A team of researchers affiliated with institutions in Denmark, Germany and Hong Kong has found that several extracts from the artemisia annua plant are active against the SARS-CoV-2 virus under laboratory conditions. In their paper published in the journal Scientific Reports, the group describes three extracts of the artemisia annua plant they tested and how they fared in combating the SARS-CoV-2 virus in human lung tissue. While the main focus of the pandemic has in recent months become the vaccines that are effective for prevention of COVID-19, work continues on treatments for those unvaccinated people who become infected with the SARS-CoV-2 virus.

Frontiers Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective

Small molecules in the treatment of COVID-19

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach

Frontiers Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus

Coronavirus: What do we know about the artemisia plant?

Foods, Free Full-Text

Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro

Covid 19 coronavirus: Medsafe blocks sales of 'treatment' Artemisia annua - NZ Herald

Traditional Japanese food may hold building blocks of COVID-19 treatments